- Home
- INKT vs FLGC Comparison
INKT vs FLGC Comparison
Compare INKT & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- FLGC
- Stock Information
- Founded
- INKT 2017
- FLGC 2019
- Country
- INKT United States
- FLGC United States
- Employees
- INKT N/A
- FLGC N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- FLGC Health Care
- Exchange
- INKT Nasdaq
- FLGC Nasdaq
- Market Cap
- INKT 28.5M
- FLGC 26.5M
- IPO Year
- INKT 2021
- FLGC 2021
- Fundamental
- Price
- INKT $0.75
- FLGC $1.17
- Analyst Decision
- INKT Strong Buy
- FLGC Strong Buy
- Analyst Count
- INKT 2
- FLGC 3
- Target Price
- INKT $6.50
- FLGC $6.50
- AVG Volume (30 Days)
- INKT 32.0K
- FLGC 533.2K
- Earning Date
- INKT 11-14-2024
- FLGC 11-13-2024
- Dividend Yield
- INKT N/A
- FLGC N/A
- EPS Growth
- INKT N/A
- FLGC N/A
- EPS
- INKT N/A
- FLGC N/A
- Revenue
- INKT N/A
- FLGC $64,154,000.00
- Revenue This Year
- INKT N/A
- FLGC N/A
- Revenue Next Year
- INKT N/A
- FLGC $19.90
- P/E Ratio
- INKT N/A
- FLGC N/A
- Revenue Growth
- INKT N/A
- FLGC N/A
- 52 Week Low
- INKT $0.57
- FLGC $0.70
- 52 Week High
- INKT $1.90
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- INKT 54.46
- FLGC 40.65
- Support Level
- INKT $0.74
- FLGC $1.11
- Resistance Level
- INKT $0.80
- FLGC $1.63
- Average True Range (ATR)
- INKT 0.05
- FLGC 0.18
- MACD
- INKT 0.01
- FLGC -0.05
- Stochastic Oscillator
- INKT 62.60
- FLGC 6.67
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.